IXHL - Incannex Announces Participation at the H.C. Wainwright 25th Annual Global Investment Conference - September 11-13 2023 | Benzinga
MELBOURNE, Australia, Sept. 08, 2023 (GLOBE NEWSWIRE) -- Incannex Healthcare Limited (NASDAQ:IXHL) (ASX: IHL), (‘Incannex' or the ‘Company') a pharmaceutical company developing cannabinoid pharmaceutical medicines and psychedelic therapies for unmet medical needs, is pleased to announce that it will be featured as a presenting company at the H.C. Wainwright 25th Annual Global Investment Conference - September 11-13, 2023. Incannex will be presenting and taking one on one meetings virtually. Mr Joel Latham, CEO and Managing Director of Incannex, will provide an overview of the Company's business during the presentation.
If you are an institutional investor and would like to listen to the Company's presentation or request a 1x1 meeting, please click on the following link (HCW 25th Annual Global Investment Conference Registration Link) to register for the conference.
Event: H.C. Wainwright 25th Annual Global Investment Conference
Date: September 11-13, 2023
1x1 virtual meeting availability: September 11-14, 2023, 2:00-6:00pm (U.S. eastern time)
Webcast Link: https://journey.ct.events/view/8ad31a13-d3b5-4827-948c-78e2ed2874d7
Time/Location: Virtual ...